Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05088447 · ClinicalTrials.gov registry record
A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 15
- Enrollment target
NCT05088447: Clinical Trial study, sponsored by Stanford University.
NCT05088447 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05088447 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The present application proposes to study the role the composition of the pediatric CF airway microbiota plays in frequent pulmonary exacerbations in pediatric CF patients. In order to accomplish this goal the dynamics of the composition of the CF airway microbiota in two distinct subsets of pediatric patients with CF will be characterized, those with frequent pulmonary exacerbations and clinically stable children. Clinical measures of pulmonary function, patient reported symptoms, sleep quality, and antibiotic usage will be recorded, and these findings will be correlated with the lung microbiota data. This strategy promises to identify the key characteristics of the pediatric CF microbiota, which can in turn be used as noninvasive markers to identify those patients at a higher risk for experiencing repeated pulmonary exacerbations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05088447
The ClinicalTrials.gov registry entry for NCT05088447 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05088447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05088447 about?
NCT05088447 is a clinical study titled "A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome". The present application proposes to study the role the composition of the pediatric CF airway microbiota plays in frequent pulmonary exacerbations in pediatric CF patients. In order to accomplish this goal the dynamics of the composition of the CF airway microbiota in two distinct subsets of pediat...
What is the current status of trial NCT05088447?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2015-02. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT05088447?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.